MADELINE GROTEFENDT: Open Payments
NPI 1912176280 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 45 payments from 17 companies in 2025. Trend: 2023 $928 · 2024 $1,170 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $295 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| PFIZER INC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Antares Pharma, Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
Products named: Wegovy, Rybelsus, Ozempic, Auvelity, XIFAXAN, JARDIANCE, COMIRNATY, LEQVIO.
Industry payments across TN — which companies pay providers there.
